Australia Stock Exchange release from INHALERX : Quarterly Appendix 4C Cash Flow Report
30/01/2022 23:02
Australia Stock Exchange release from INHALERX IRX.AX : Quarterly Appendix 4C Cash Flow Report
Recent news on Nexalis Therapeutics
See all newsBrief: Nexalis Therapeutics Says Sean Williams Has Resigned As Non-Executive Chairman
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval